Pharmacogenomics: Convergence of Pharmacology & Genomics
Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor. Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments. By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. Creating a personalized cancer screening and treatment plan includes: Determining the chances that a person will develop cancer and selecting screening strategies to lower the risk, Matching patients with treatments that are more likely to be effective and cause fewer side effects, Predicting the risk of recurrence (return of cancer)
- Predictive computational phenotyping
- New era of Proteomics
- Drug metabolizing enzymes
- Protein microarrays for personalized medicine
- Genotyping & genome sequencing
Related Conference of Pharmacogenomics: Convergence of Pharmacology & Genomics
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
February 18-19, 2027
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Modern Phenotypic Drug Discovery Defining the Path Forward D1
April 2 6 2016
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
February 21 25 2016
Molecular Medicine Tri-Conference 2016
March 6 - 11 2016
Cancer Center Business Summit 2016
February 24 - 25 2016
Molecular Diagnostics World Summit MolrDIAx 2016
May 19-20 2016
27th Annual Cancer Progress Conference 2016
March 8 - 9 2016
Personalized Diagnostics 2016
March 7 9 2016
Biobanking 2016
January 5-7 2016
GTCbio s Novel Immunotherapeutics Summit 2016
January 25 - 26 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
January 27-29 2016
African Pharmac 2016eutical Summit
February 24 - 25 2016
11th Annual Biomarkers Congress 2016
February 25 - 26 2016
Biomarkers Summit 2016
March 21 - 23 2016
10th Personalized Medicine World Congress 2016
January 24-27 2016
International Congress on Personalized Health Care
June 12 - 15 2016
Modern Phenotypic Drug Discovery Defining the Path Forward D1
April 2 6 2016
G Protein-Coupled Receptors Structure Signaling and Drug Discovery B3
February 21 25 2016
Molecular Medicine Tri-Conference 2016
March 6 - 11 2016
Cancer Center Business Summit 2016
February 24 - 25 2016
Molecular Diagnostics World Summit MolrDIAx 2016
May 19-20 2016
27th Annual Cancer Progress Conference 2016
March 8 - 9 2016
Personalized Diagnostics 2016
March 7 9 2016
Biobanking 2016
January 5-7 2016
GTCbio s Novel Immunotherapeutics Summit 2016
January 25 - 26 2016
6th ANNUAL PHARMACOVIGILANCE AND RISK MANAGEMENT STRATEGIES FORUM
January 27-29 2016
African Pharmac 2016eutical Summit
February 24 - 25 2016
11th Annual Biomarkers Congress 2016
February 25 - 26 2016
Biomarkers Summit 2016
March 21 - 23 2016
10th Personalized Medicine World Congress 2016
January 24-27 2016
International Congress on Personalized Health Care
June 12 - 15 2016
Pharmacogenomics: Convergence of Pharmacology & Genomics Conference Speakers
Recommended Sessions
- Advances In Molecular Diagnostics
- Approaches To Stem Cells
- Cardiology and vascular medicine
- Clinical Case Reports
- Genetics Of Ebola Outbreak
- Genomics & Personalized Medicine
- Immunology infectious disease
- Lifestyle Medicine
- Market Strategies & Challenges In Personalised Medicine
- Nanotechnology: Future Of Personalised Medicine
- Paths Of Biomarkers
- Personalised Medicine In 21st Century
- Personalized Drug Therapy
- Personalized Medicine & its Innovations
- Personalized oncology
- Pharmacogenomics: Convergence of Pharmacology & Genomics
- Preventive Medicines
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)